Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

ARUK Consortium, Sims, Rebecca, GERAD/PERADES, CHARGE, ADGC, EADI, van der Lee, Sven J, Naj, Adam C, Bellenguez, Céline, Badarinarayan, Nandini, Jakobsdottir, Johanna +443 more·2017·Nature Genetics
DOI 10.1038/ng.3916

Cited by (1,043)

Items 801–900 of 1,043

  1. Protein kinase C eta enhances Golgi-localized signaling and is associated with Alzheimer’s disease using a recessive mode of inheritance
    Maria Celeste Gaurón, Dmitry Prokopenko, Sanghun Lee, Sarah A. Wolfe, Julian Hecker, Julian Willett, Mohammad Waqas, Gema Lordén, Yimin Yang, Joshua E. Mayfield et al. · 2025 · medRxiv
  2. Subjective Cognitive Decline and Genetic Propensity for Dementia beyond Apolipoprotein ε4: A Systematic Review
    Stefanos N. Sampatakakis, Maria Roma, Nikolaos Scarmeas · 2024 · Current Issues in Molecular Biology
  3. Genome sequencing for early-onset dementia: high diagnostic yield and frequent observation of multiple contributory alleles
    J. Nicholas Cochran, Emily McKinley, Meagan Cochran, Michelle D. Amaral, Bryan A. Moyers, Brittany N. Lasseigne, David E. Gray, James M.J. Lawlor, Jeremy W. Prokop, Ethan G. Geier et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  4. Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases
    Haocheng Lu, Jifeng Zhang, Y. Eugene Chen, Minerva T. Garcia-Barrio · 2021 · Cardiovascular Drugs and Therapy
  5. INPP5D expression is associated with risk for Alzheimer’s disease and induced by plaque-associated microglia
    2020
  6. Identifying Network Biomarkers for Alzheimer’s Disease Using Single-Cell RNA Sequencing Data
    Ioannis Aslanis, Marios G. Krokidis, Georgios Ν. Dimitrakopoulos, Aristidis G. Vrahatis · 2023 · Advances in experimental medicine and biology
  7. APOE ‐stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's Disease
    Fuhai Li, Yike Chen, Daniel Western, Muhammad Ali, Menghan Liu, Katherine Gong, Ying Xu, Joseph Lowery, David M. Holtzman, Chloe Robins et al. · 2026 · Advanced Science
  8. Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice
    2023
  9. Pyroptosis; igniting neuropsychiatric disorders from mild depression to aging-related neurodegeneration
    Kiavsh Hushmandi, Russel Joseph Reiter, Najma Farahani, William Chi Shing Cho, Mina Alimohammadi, Seyedeh Mahdieh Khoshnazar · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  10. BioMedGraphica: An All-in-One Platform for Joint Textual Biomedical Prior Knowledge and Numeric Graph Generation
    2024
  11. Phospholipase D3 contributes to Alzheimer’s disease risk via disruption of Aβ clearance and microglia response to amyloid plaques
    Matthew J Rosene, Simon Hsu, Shih Feng You, Logan Brase, Anthony C. Verbeck, Rita J. Martinez, Clare E. Wallace, Zeran Li, Ping Yan, Nina M. Dräger et al. · 2022 · medRxiv
  12. Evaluating the Classification Accuracy of Expression Quantitative Trait Loci Calculated Polygenic Risk Scores in Alzheimer’s Disease
    Keeley J. Brookes · 2023 · International Journal of Molecular Sciences
  13. IPSC-derived neuronal cultures expressing the Alzheimer’s disease associated rare TREM2 R47H variant enables the construction of an Aβ-induced gene regulatory network
    2019
  14. Integration of Alzheimer’s GWAS, 3D genomics, and single-cell CRISPRi non-coding screen implicates causal variants in a microglial enhancer regulating TSPAN14
    Shannon Laub, Natalia M. Tulina, Matthew Hoffman, Joe Faryean, Sandhya Ramachandran, Bao Khanh Trang, Stephanie M. Lewkiewicz, Alessandra Chesi · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Lipid associated polygenic enrichment in Alzheimer’s disease
    Iris Broce, Chin Hong Tan, Chun Chieh Fan, Aree Witoelar, Natalie Wen, Iris E. Jansen, Christopher Paul Hess, William P. Dillon, Christine M. Glastonbury, M. Maria Glymour et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  16. A Risk Variant rs6922617 in TREM Is Discrepantly Associated With Defining Neuropathological Hallmarks in the Alzheimer’s Continuum
    Shuangjie Qian, Yi Zheng, Tao Jiang, Jialong Hou, Ruixue Cao, Jinlai Cai, Enzi Ma, Wenwen Wang, Weihong Song, Chenglong Xie · 2024 · The Journals of Gerontology Series A
  17. Glia in Neurodegenerative Disease
    Gerard Crowley, David Attwell, Hemali P. Phatnani, Harald W. Sontheimer, Soyon Youngae Hong · 2024 · Cold Spring Harbor Perspectives in Biology
  18. Multiple Sclerosis Polygenic Risk Is Not Enriched in Three Multicase Families in Comparison to Population-Based Cases
    Ming Chen, Allan Motyer, Bruce V. Taylor · 2024 · Human Mutation
  19. Different Splice Isoforms of Peripheral Triggering Receptor Expressed on Myeloid Cells 2 mRNA Expressions are Associated With Cognitive Decline in Mild Dementia Due to Alzheimer’s Disease and Reflect Central Neuroinflammation
    Yi-Kuan Chiang, Yung‐Shuan Lin, Chun‐Yu Chen, Jiing-Feng Lirng, Yu‐Hsiu Yang, Wei‐Ju Lee, Jong‐Ling Fuh · 2024 · American Journal of Alzheimer s Disease & Other Dementias®
  20. The intrinsically disordered cytoplasmic tail of a dendrite branching receptor uses two distinct mechanisms to regulate the actin cytoskeleton
    Kramer, Daniel A., Narvaez-Ortiz, Heidy Y., Patel, Urval, Shi, Rebecca, Shen, Kang, Nolen, Brad J., Roche, Julien, Chen, Baoyu · 2022
  21. Genetically elevated high‐density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease
    Gina Marie Peloso, Sven J. van der Lee, International Genomics of Alzheimer's Project (IGAP), Rebecca Sims, Sven J. van der Lee, Adam Christian Naj, Céline Bellenguez, Nandini Badarinarayan, Jóhanna Jakobsdóttir, Brian W. Kunkle et al. · 2018 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  22. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease
    Jin Xu, Giulia Bankov, Min Gyu Kim, Asger Wretlind, Jodie Lord, Rebecca Green, Angela Hodges, Abdul Hye, Dag Aarsland, Latha Velayudhan et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimer’s disease
    2025
  24. Uncovering systems-level molecular similarities between Alzheimer’s and Parkinson’s diseases
    Hossein Fallahi, Mehran Radak, Zahra Sadat Yadegari · 2023 · Neuroscience and Behavioral Physiology
  25. Plaque attack by microglial PLCγ2
    Ashley L. Comer, Timothy R. Hammond · 2023 · Immunity
  26. Genetic drivers of hippocampal atrophy highlight the role of APOE functional variants and AD polygenicity in Mild Cognitive Impairment
    Natàlia Vilor‐Tejedor, Albert Rodrigo, Patricia Genius, Blanca Rodríguez‐Fernández, Federica Anastasi, Wiesje Pelkmans, Arcadi Navarro, Hieab H.H. Adams, Laura E.M. Wisse, Juan Domingo Gispert et al. · 2025 · NeuroImage Clinical
  27. CSF proteomic analysis of semorinemab Ph2 trials in prodromal-to-mild (Tauriel) and mild-to-moderate (Lauriet) Alzheimer’s disease identifies distinct trial cell-type specific proteomic signatures
    Alyaa M. Abdel‐Haleem, Ellen Casavant, Balázs István Tóth, Edmond Teng, Cecília Monteiro, Nikhil Janak Pandya, Casper C. Hoogenraad, Brad A. Friedman, Felix L. Yeh, Veronica G. Anania et al. · 2024 · medRxiv
  28. Impaired Signaling of NF-κB and NRF2 in CX3CR1-Deficient Microglia: Implications in Tauopathies
    Sara Castro‐Sánchez, Ángel J. García‐Yagüe, Sebastian Kügler, Isabel Lastres‐Becker · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Generation of Neural Stem Cells from Pluripotent Stem Cells for Characterization of Early Neuronal Development
    Matthias Jung, Jovita Schiller, Carla Hartmann, Jenny Pfeifer, Dan Rujescu · 2021 · Methods in molecular biology
  30. Association of low-frequency and rare coding variants with information processing speed
    Jan Bressler, Gail Davies, Albert V. Smith, Yasaman Saba, Joshua C. Bis, Xueqiu Jian, Caroline Hayward, Lisa R. Yanek, Jennifer A. Smith, Saira Saeed Mirza et al. · 2021 · Translational Psychiatry
  31. Non-Coding Genetic Analysis Implicates Interleukin 18 Receptor Accessory Protein 3′UTR in Amyotrophic Lateral Sclerosis
    Chen Eitan, Aviad Siany, Elad Barkan, Tsviya Olender, Kristel R. van Eijk, Matthieu Moisse, Sali M.K. Farhan, Yehuda Matan Danino, Eran Yanowski, Hagai Marmor-Kollet et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Control of microglial dynamics by the Arp2/3 complex and the autism- and schizophrenia-associated protein CYFIP1
    Scott-Solache, James, Pei, Jiaxin, Drew, James, López-Doménech, Guillermo, Jolivet, Renaud B., Nieto-Rostro, Manuela, Davenport, Elizabeth C., Arancibia-Cárcamo, I. Lorena, Attwell, David, Kittler, Josef T. · 2026 · Proceedings of the National Academy of Sciences
  33. Preclinical development of an immunoassay for the detection of TREM2: a new biomarker for Alzheimer’s disease
    Walter W. Hu, Huimei Zeng, Jiaqi Lü, Tianpeng Li, Xue Liu, Yang Liu, Weihuan Wen, Weijun Shen, Hongying Chen, Zhicheng Chen · 2025 · Scientific Reports
  34. The Role of Adaptive and Innate Immunity in Alzheimer’s Disease
    Clive Holmes · 2021 · Cambridge University Press eBooks
  35. Identification of novel Alzheimer’s disease genes co-expressed with TREM2
    Joseph S. Reddy, Mariet Allen, Xue Wang, Joanna M. Biernacka, Brandon J. Coombes, Gregory D. Jenkins, Jason P. Sinnwell, Minerva M. Carrasquillo, Cyril P. Pottier, Yingxue Ren et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  36. MiR-34a deficiency enhances nucleic acid sensing and type I IFN signaling in a mouse model of Alzheimer’s disease
    2025
  37. Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers
    Jeskanen, Heli, Heikkinen, Sami, Kervinen, Inka, Lehtisalo, Jenni, Ngandu, Tiia, Willman, Roosa-Maria, Rosa, Jessica, Hoffmann, Dorit, FinnGen, Leinonen, Ville et al. · 2026 · Alzheimer's Research & Therapy
  38. Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals
    Mikko Koivumäki, Henna Martiskainen, Mari Takalo, Jenni Lehtisalo, Tiia Ngandu, FinnGen, Anniina Snellman, Mikko O. Hiltunen, Juha O. Rinne · 2026 · Alzheimer s Research & Therapy
  39. Rare Variant Aggregation in 148,508 Exomes Identifies Genes Associated with Proxy Alzheimer’s disease/Dementia
    Douglas P. Wightman, Jeanne E. Savage, Christiaan de Leeuw, Iris E. Jansen, Danielle Posthuma B · 2021 · medRxiv
  40. Future Immunotherapy Challenges and Perspectives
    Amrita Date, Vandana S. Nikam, Safiuddin Shoeb Syed · 2020 · Springer eBooks
  41. Genetic evidence supports therapeutic modulation of progranulin levels in Alzheimer’s Disease
    Chloe Robins, John D. Eicher, Jimmy Liu, Yancy Lo, Tom G. Richardson, Daniel Western, Jonathan Davitte, Carlos Cruchaga, Alzheimer’s Disease Neuroimaging Initiative, Umesh Kumar et al. · 2026 · Molecular Neurodegeneration Advances
  42. Network Medicine and Alzheimer’s Disease Therapy
    2018
  43. Alzheimer’s Disease variant portal (ADVP): a catalog of genetic findings for Alzheimer’s Disease
    2020
  44. Manifestations of Alzheimer’s Disease Genetic Risk in the Blood: A Cross-Sectional Multi-Omic Analysis in Healthy Adults Aged 18-90+
    Laura M. Heath, John C. Earls, Andrew T. Magis, Sergey A. Kornilov, Jennifer C. Lovejoy, Cory C. Funk, Noa Rappaport, Benjamin A. Logsdon, Lara M. Mangravite, Brian W. Kunkle et al. · 2022 · Research Square
  45. A comparative study of structural variant calling strategies using the Alzheimer’s Disease Sequencing Project’s whole genome family data
    John Stephen Malamon, John J. Farrell, Li Charlie Xia, Beth A. Dombroski, Wan‐Ping Lee, Gautami Das, Badri Narayan Vardarajan, Jessica Way, Amanda B Kuzma, Otto Valladares et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Decoding Alzheimer's Disease One Cell Class at a Time
    Martin Darvas, David G. Cook, Annalisa Scimemi · 2026 · Cellular and Molecular Neurobiology
  47. Immunogenetic mechanism driving neurological and neurodegenerative disorders
    Younis Ahmad Hajam, Premlata Premlata, Raksha Rani, Riya Sharma, Preeti Sharma, Rajesh Kumar · 2022 · Elsevier eBooks
  48. Leveraging gene co-regulation to identify gene sets enriched for disease heritability
    2021
  49. The TMEM106B rs1990621 protective variant is also associated with increased neuronal proportion
    Zeran Li, Fabiana Geraldo Farias, Umber Dube, Jorge L. Del‐Aguila, Kathie A. Mihindukulasuriya, María Victoria Fernández, Laura Ibáñez, John Budde, Fengxian Wang, Allison M. Lake et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  50. What does heritability of Alzheimer’s disease represent?
    2022
  51. Targeted plasma metabolomics reveals potential biomarkers of the elderly with mild cognitive impairment in Qingdao rural area
    Yuchi Meng, Murong Cheng, Hongyan Qu, Zhenxue Song, Ling Zhang, Yuanjun Zeng, Dongfeng Zhang, Suyun Li · 2024 · Frontiers in Aging Neuroscience
  52. Personalized single-cell transcriptomics reveals molecular diversity in Alzheimer’s disease
    Pramod Bharadwaj Chandrashekar, Sayali Anil Alatkar, Noah Cohen Kalafut, Ting Jin, Chirag Gupta, Ryan Conway Burczak, Huang Xiang, Shuang Liu, Athan Z. Li, Aram Hong et al. · 2026 · Nature Communications
  53. Biophysical characterization of TREM2 missense variants implicated in neurodegenerative disease
    Joshua P. Pillai, Kijung Sung, Linda Zhixia Shi, Chengbiao Wu · 2025 · Computational and Structural Biotechnology Journal
  54. A bibliometric analysis of the immune system and cognitive impairment: trends from 1985 to 2024
    Beibei Zou, Jinxi Xiang, M. Zhang, Jing Huang, Chao Feng · 2025 · Frontiers in Aging Neuroscience
  55. Polygenic risk score analysis identifies deleterious protein-coding variants in novel immune pathway genes ATP8B4, FCGR1A, and LILRB1 that associate with Alzheimer’s disease.
    Joseph S. Reddy, Xue Wang, Mariet Allen, Minerva M. Carrasquillo, Joanna M. Biernacka, Gregory D. Jenkins, Brandon J. Coombes, Olivia Belbin, Todd Eliot Golde, Nilüfer Ertekin‐Taner et al. · 2022 · Research Square
  56. Microfluidics-free single-cell genomics reveals complex central-peripheral immune crosstalk in the mouse brain during peripheral inflammation
    Malú G. Tansey, Jake Sondag Boles, Oihane Uriarte Huarte · 2023 · Research Square
  57. First GWAS on Alzheimer’s Disease in Argentina and Chile populations
    Maria Carolina Dalmasso, Itziar de Rojas, Natividad Olivar, Carolina Muchnik, Bárbara Angel B, Sergio Gloger, Mariana Soledad Sanchez Abalos, María Victoria Chacón, Rafael Aránguiz, Paulina Orellana et al. · 2023 · medRxiv
  58. Novel small molecules inhibit proteotoxicity and inflammation: Mechanistic and therapeutic implications for Alzheimer’s Disease, healthspan and lifespan- Aging as a consequence of glycolysis
    Rachel R Litke, James M. Vicari, Bik Tzu Huang, Lila R. Shapiro, Kun-Hyung Roh, Aaron E. Silver, Pooja Talreja, Nicolle Palacios, Yonejung Yoon, Christopher Paul Kellner et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Mapping microglial mechanisms in Alzheimer’s disease: a comprehensive analysis
    Xiaofang Wang, Yuqing Guo, Yonghan Zha, Shuling Wang, Weihua Yang, Qianfang Jia · 2025 · Experimental Biology and Medicine
  60. New Insights into Microglia as Therapeutic Targets in Alzheimer’s Disease
    Deepa S. Mandlik, Satish K. Mandlik, Heena Bholaram Choudhary · 2023 · Current Drug Therapy
  61. Enhanced Activity of Alzheimer Disease-associated Variant of Protein Kinase Cα Drives Cognitive Decline
    2021
  62. MiR-34a deficiency enhances nucleic acid sensing and type I IFN signaling in a mouse model of Alzheimer’s disease
    Junling Yang, George E. Tsourdinis, Charlotte Holas, Mark Maienschein‐Cline, Robert Lalonde, Ken-ichiro Fukuchi · 2026 · Frontiers in Immunology
  63. Variable and interactive effects of Sex, APOE ε4 and TREM2 on the deposition of tau in entorhinal and neocortical regions
    J. Giorgio, Caroline Jonson, Yi-Lin Wang, Jennifer S. Yokoyama, Jing-Shen Wang, W. Jagust · 2024 · Research Square
  64. Unveiling unified patterns in Alzheimer’s disease subtypes: An SCCA clustering approach integrating PET imaging and genomics data
    Fan Yang, Matthew Maher, Richa Saxena, Joyita Dutta · 2026 · Imaging Neuroscience
  65. Comparative lipidomics of iPSC-derived microglia protocols reveal lipid droplet and immune differences mediated by media composition
    Aiko Robert, Amanda McQuade, Sascha Koppes-den Hertog, Lena Erlebach, Deborah Kronenberg‐Versteeg, Martin Kampmann, Martin A. Giera, Rik van der Kant · 2026 · Stem Cell Reports
  66. The hypermorphic PLCγ2 S707Y variant dysregulates microglial cell function – insight into PLCγ2 activation in brain health and disease, and opportunities for therapeutic modulation
    2023
  67. Human IL-34 Deficiency Primes Microglia Toward Alzheimer’s Disease-Associated States
    Francisco Hernández-Rasco, RM Romero Ruiz, Itziar de Rojas, Raquel Puerta, Clara Garcia-Mayor, Ana M. Espinosa‐Oliva, Juan García‐Revilla, Paula Bayón-Buján, Alberto Rivera-Ramos, Farah Real Oualit et al. · 2026 · medRxiv
  68. The effect of Alzheimer’s disease-associated genetic variants on longevity
    2021
  69. Three Decades of Dementia Research: Insights from One Small Community of Indomitable Rotterdammers
    Frank J. Wolters, Hieab H.H. Adams, Daniël Bos, Silvan Licher, M. Arfan Ikram · 2018 · Journal of Alzheimer s Disease
  70. Transcriptional landscape of human microglia reveals robust gene expression signatures that implicates age, sex and APOE-related immunometabolic pathway perturbations
    Tulsi Patel, Troy Carnwath, Xue Wang, Mariet Allen, Sarah Lincoln, Laura J. Lewis‐Tuffin, Zachary Quicksall, Shu Lin, Frederick Q Tutor‐New, Charlotte C.G. Ho et al. · 2021 · Research Square
  71. TREM2-H157Y Increases Soluble TREM2 Production and Reduces Amyloid Pathology
    2021
  72. Neurofilament degradation is involved in laparotomy-induced cognitive dysfunction in aged rats
    2020
  73. Abi3 S212F Alzheimer's disease variant alters plaque structure and disrupts microglia
    Claire Ann Butler, Min Sung Gee, Katie O'Gara, Giedre Milinkeviciute, Celia Da Cunha, Shimako Kawauchi, Yueh-Hao Lu, Nellie E. Kwang, Kate Inman Tsourmas, Christiana A. Prekopa et al. · 2026 · Alzheimer s & Dementia
  74. Uncoupling of synaptic loss from amyloid burden by an Alzheimer’s disease protective variant of PLCγ2
    Ryan J. Bevan, Emily Maguire, Tom J. Phillips, Elena Simonazzi, Marieta Vassileva, Julie H. Williams, Philip R. Taylor · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  75. TREM2 Risk Variants with Alzheimer’s Disease Differ in Rate of Cognitive Decline
    2024
  76. Penetrance estimation of SORL1 loss-of-function variants using a family-based strategy adjusted on APOE genotypes suggest a non-monogenic inheritance
    Catherine Schramm, Camille Charbonnier, Aline Zaréa, Morgane Lacour, David Wallon, CNRMAJ collaborators, Anne Boland, Jean‐François Deleuze, Robert Olaso, Flora Alarcon et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Single-Cell Transcriptomic Analysis by Deep Learning Identifies Novel Microglial Transcription Regulations in Alzheimer’s Disease
    Maitry Ronakbhai Trivedi, Jay Shah, Yi Su, Eric M. Reiman, Teresa Wu, Qi Wang · 2026 · AI in neuroscience.
  78. Peripheral endotoxin exposure in mice activates crosstalk between phagocytes in the brain and periphery
    Jake Sondag Boles, Oihane Uriarte Huarte, Malú G. Tansey · 2024 · Research Square
  79. Microglial ITAM & ITIM Signaling in Neurodegenerative Disease and Brain Aging
    Aman Mangalmurti, Amelia Bonheur, John R. Lukens · 2026 · Journal of Molecular Biology
  80. Microglial mitophagy as an immunometabolic checkpoint in alzheimer’s disease: linking mitochondrial quality control to neuroinflammation
    Mingyue Zou, Tengyu Zhao, Weidong Wu, J Y Zhang, Pengyu Pan, Jingdong Yan, Quan Li, Yanyan Zhou · 2026 · Journal of Neuroinflammation
  81. Visualising the Knowledge Structure of Microglia in Alzheimer’s Disease: A CiteSpace Analysis
    Qi Wang, X C Zhang, Delong Wang, Xinyu Jiang, Yanyan Zhou, Te Zhang, Xueying Yang, L.-Z. Liu, Quan Li · 2025 · Journal of Multidisciplinary Healthcare
  82. Aberrant accumulation of age- and disease-associated factors following neural probe implantation in a mouse model of Alzheimer’s disease
    S. Wellman, Olivia A. Coyne, Madeline M. Douglas, T. Kozai · 2023 · bioRxiv
  83. Identification of Causality Among Gene Mutations Through Local Causal Association Rule Discovery
    2018
  84. Analysis of exome sequencing data implicates rare coding variants in STAG1 and ZNF136 in schizophrenia
    Sophie L Chick, Peter Holmans, Detelina Grozeva, Rebecca Sims, Julie H. Williams, Michael John Owen, Michael C. O’Donovan, James Walters, Elliott Rees · 2024 · medRxiv
  85. Alzheimer's Protection by <scp>PLCγ2</scp> Compacts Plaques, Redistributes Microglia, and Protects Synapses in <scp> <i>App</i> <sup> <i>NL</i> </sup> </scp> <sup> <i>‐G‐F</i> </sup> Mice
    Bevan, Ryan J., Maguire, Emily, Mackinnon, Eilish, Salis, Elisa, Phillips, Thomas, Simonazzi, Elena, Vassileva, Marieta, Allen, Nicholas D., Williams, Julie, Taylor, Philip R. · 2026 · Glia
  86. Mechanisms of increased Alzheimer’s disease pathology with R47H and R62H TREM2 variants
    Nurun Nahar Fancy, Nanet Willumsen, Vicky M. N. Chau, Samuel L Boulger, Harry J. Whitwell, Wenhao Wang, Baptiste Avot, Michael Thomas, Jonathan Talbot-Martin, Stergios Tsartsalis et al. · 2026 · Acta Neuropathologica
  87. Evaluation of gene-based family-based methods to detect novel genes associated with familial late onset Alzheimer disease
    2018
  88. Integrative genomics and single-cell CRISPRi screening dissect Alzheimer GWAS non-coding variants regulating TSPAN14
    Shannon Laub, Natalia M. Tulina, Matthew Hoffman, Joe Faryean, Sandhya Ramachandran, Bao Khanh Trang, Stephanie M. Lewkiewicz, Alessandra Chesi · 2026 · The American Journal of Human Genetics
  89. A guide to selecting high-performing antibodies for PLC-gamma-2 for use in Western Blot, immunoprecipitation and immunofluorescence
    Ruíz Moleón, Vera, Fotouhi, Maryam, Alende, Charles, Ayoubi, Riham, Bedford, Logan M., Southern, Kathleen, Richardson, Timothy I., Laflamme, Carl, NeuroSGC/YCharOS/EDDU collaborative group, ABIF consortium · 2024 · F1000Research
  90. Integrated genomic analysis and CRISPRi implicates EGFR in Alzheimer’s disease risk
    2025
  91. Genetics and Epigenetics in the Neurodegenerative Disorders of the Central Nervous System
    Chiara Fenoglio · 2018 · Springer eBooks
  92. Heterozygous expression of the Alzheimer’s disease protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses.
    Shiden Solomon, Nirmal Kumar Sampathkumar, Ivo Carre, Mrityunjoy Mondal, George Chennell, Anthony Christopher Vernon, Marc‐David Ruepp, Jacqueline C. Mitchell · 2022 · Research Square
  93. Amyloid-beta and tau pathologies are both necessary to induce novel stage-specific microglia subtypes during Alzheimer’s disease progression
    Dong Won Kim, Kevin J. Tu, Alice Wei, Ashley Lau, Anabel Gonzalez-Gil, Tianyu Cao, Kerstin E. Braunstein, Jonathan P. Ling, Juan Carlos Troncoso, Philip C. Wong et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Polygenic risk score analysis identifies deleterious protein-coding variants in novel immune pathway genes ATP8B4, FCGR1A , and LILRB1 that associate with Alzheimer’s disease
    Joseph S. Reddy, Xue Wang, Mariet Allen, Minerva M. Carrasquillo, Joanna M. Biernacka, Gregory D. Jenkins, Brandon J. Coombes, Olivia Belbin, Todd Eliot Golde, Nilüfer Ertekin‐Taner et al. · 2022 · medRxiv
  95. An activity-guided map of electrophile-cysteine interactions in primary human immune cells
    2019
  96. Integrated systems biology approaches in chronic disease research
    Munichandra Babu Tirumalasetty, Mayank Choubey · 2025 · Elsevier eBooks
  97. Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, while the Alzheimer’s R47H mutant does the opposite
    2020
  98. The Role of Microglial-Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) in Neuronal Homeostasis and Tau Pathogenesis
    Vaishnavi Jadhav · 2021 · IUScholarWorks (Indiana University)
  99. Phosphoinositide turnover through PLCγ regulates Draper-dependent engulfment in glia
    Freya Storer, E. A. MacKinnon, Hannah Clarke, Daniel C. Maddison, Leonardo Amadio, Thejaswini Susobhanan, Bilal R. Malik, Owen M. Peters, Gaynor Ann Smith · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Intelligent diagnostic technology in multi-party joint intervention to explore improvement of neurocognitive status
    Wei Baojian, Lang Yanmei, Chunyu Li · 2020 · Journal of Intelligent & Fuzzy Systems